Novo Nordisk: Novo Nordisk owner to invest $200 million in quantum computing startups

Novo Holdings, the investment arm of the Novo Nordisk Foundation, has 77% of voting shares in Novo Nordisk, which is known for producing blockbuster obesity drug Wegovy and diabetes treatment Ozempic.

Related Keywords

Denmark ,Danish ,Soren Moller ,Technology Leadership ,Indian School Of Business ,Offering College ,Novo Nordisk Foundation ,Novo Holdings ,Novo Nordisk ,Tech Prowess ,High Value Skill ,